Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed August 9, 2026.
AstraZeneca PLC is a company within the Pharmaceuticals & Biotechnology category. AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates in major therapeutic areas including Oncology, Rare Diseases, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Known for its 'What science can do' philosophy, it maintains major global R&D centers in the UK, Sweden, and the US.
AstraZeneca PLC was founded in 1999 and is headquartered in Cambridge, UK.
AstraZeneca PLC is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for AstraZeneca PLC is Moderate. Significant factual deltas detected. Inconsistent representation across models.
AI models classify AstraZeneca PLC as a Challenger. AI names competitors first.
AstraZeneca PLC appeared in 7 of 8 sampled buyer-intent queries (88%). While the brand dominates technical medical queries, it faces a gap in 'next-generation' discovery where AI might prioritize newer biotech startups for cell therapy queries.
The brand is perceived as a science-led global powerhouse with a heavy emphasis on innovation and 'what science can do.' While its historical identity is tied to broad-market medicine, AI increasingly recognizes its shift toward high-value specialty areas like rare diseases and cell therapy. Key gap: AI often focuses heavily on the COVID-19 vaccine legacy, whereas the brand's current identity is pivoting aggressively toward Rare Disease and Next Generation Therapeutics.
Of 6 key facts verified about AstraZeneca PLC, 4 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The recency of financial data (Q1 2026) and specific pipeline counts (186) will likely lead to hallucinations or outdated figures in AI responses.
Buyers turn to AstraZeneca PLC for Lifestyle Management: Traditional lifestyle changes or diet-based interventions for chronic conditions before clinical diagnoses., Custom Research Solutions: Hiring specialized medical research firms or CROs for bespoke therapeutic development within a health system., among 2 documented problem areas.
Buyers evaluating AstraZeneca PLC typically ask AI models about "top oncology pharmaceutical companies", "biotech companies in Cambridge UK", "pharmaceutical companies focusing on rare diseases", and 3 similar queries.
AstraZeneca PLC's core products are Prescription medicines in Oncology, Rare Disease, CVRM, and Respiratory..
AstraZeneca PLC uses Enterprise/Custom (Healthcare systems & Insurance).
AstraZeneca PLC serves Global healthcare providers, hospitals, pharmacy benefit managers, and government health agencies..
AstraZeneca PLC A massive, 'catalyst-rich' pipeline of 186 projects led by a science-first culture and a specific focus on high-value Phase III programs in Rare Disease and Oncology.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
Official website: https://astrazeneca.com/
Last analyzed: August 9, 2026
Founded: 1999 (via merger) (source: official website)
Headquarters: Cambridge, United Kingdom (source: official website)
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile